Skip to Content

Join the 'Seizures' group to help and get support from people like you.

Seizures News

Related terms: Complex Partial Seizure, Fits, Absence Seizure

Helping a Child Manage a Chronic Illness

Posted 4 days ago by Drugs.com

THURSDAY, July 21, 2016 – Children and teens who feel confident handling a chronic illness on their own appear better able to learn to manage their health as adults, a new study finds. The University of North Carolina investigators concluded that kids who believe their health is controlled by adults or by chance may not develop the health self-management skills they will need as adults. This could put them at increased risk for health problems. The study included 163 youngsters, aged 6 to 17, attending a camp for young people with chronic diseases. Researchers asked the participants whether they felt they had control over their health. The researchers also assessed whether the children took medications as prescribed and their readiness to transition to adult care. Feeling confident about managing their own health and being ready to transition to adult care likely indicate that ... Read more

Related support groups: Seizures, Asthma, Epilepsy, Asthma - Maintenance, Diabetes, Type 1, Seizure Prevention, Asthma - Acute, Seizure Prophylaxis, Allergic Asthma, Reversible Airways Disease, Reversible Airways Disease - Maintenance

Epilepsy May Triple ADHD Risk, Danish Study Finds

Posted 12 days ago by Drugs.com

WEDNESDAY, July 13, 2016 – Children who suffer from epilepsy or fever-related seizures may face a higher risk of also having attention-deficit/hyperactivity disorder (ADHD), new Danish research suggests. The findings echo those of some previous research. But, U.S. experts said the new study is notable because of the large number of study participants – nearly 1 million – and the length of follow-up, which was up to 22 years. The study looked at children born in Denmark from 1990 through 2007, tracking them until 2012. The investigators found those with epilepsy seemed to have nearly three times the risk of developing ADHD compared to children without epilepsy. And children who had fever-related seizures appeared to have an almost 30 percent increased risk of ADHD. Children with both epilepsy and fever-related seizures had a risk of ADHD more than three times higher than those without ... Read more

Related support groups: Seizures, Attention-Deficit Hyperactivity Disorder (ADHD), Fever, Epilepsy, Oppositional Defiant Disorder, Seizure Prevention, Seizure Prophylaxis, Executive Function Disorder

Childhood Vaccinations Rarely Spur Seizures, Study Finds

Posted 6 Jun 2016 by Drugs.com

MONDAY, June 6, 2016 – Certain vaccines can trigger fever-related seizures in young children, but the risk is so low that pediatricians might see one case every five to 10 years, a new study estimates. It has long been known that some vaccines carry a small seizure risk. But the researchers said the new report offers some hard numbers. And it suggests that even when babies and toddlers get three vaccines at once, they only develop fever-related seizures at a rate of 30 per 100,000 – at most. The findings should be "reassuring" to parents, said lead researcher Dr. Jonathan Duffy, of the U.S. Centers for Disease Control and Prevention. "Looking at the big picture, the benefits of vaccination are much greater than the risk of febrile [fever-related] seizures," Duffy said. Up to 5 percent of young children will have a fever-related seizure at some point, according to the CDC. It usually ... Read more

Related support groups: Seizures, Fever, Seizure Prevention, BCG, Zostavax, Yellow Fever Vaccine, Gardasil, Seizure Prophylaxis, Prevnar 13, Prevnar, Tetanus Toxoid, Vivotif Berna, Rabies Vaccine, Human Diploid Cell, Hepatitis B Adult Vaccine, FluLaval, Twinrix, Typhoid Vaccine, Live, Pneumovax 23, Varicella Virus Vaccine, Vivotif Berna Vaccine

At Least 1 Full-Time Nurse Per School, Pediatric Group Recommends

Posted 23 May 2016 by Drugs.com

MONDAY, May 23, 2016 – Every school should have at least one full-time registered nurse, a new American Academy of Pediatrics (AAP) policy statement says. "School nursing is one of the most effective ways to keep children healthy and in school and to prevent chronic absenteeism," Dr. Breena Welch Holmes, a lead author of the policy statement and chair of the AAP Council on School Health, said in an AAP news release. But school district policies about nurses may lack uniformity. And such policies often need updating, the AAP noted. In the past, the AAP supported having one school nurse for every 750 healthy students and one nurse for every 225 students who needed professional nursing assistance. But these ratios aren't enough to meet the health needs of today's students, the new policy says. "As student health needs became more complex, the school nursing role has expanded to include ... Read more

Related support groups: Diabetes, Type 2, Seizures, Allergic Reactions, Allergies, Attention-Deficit Hyperactivity Disorder (ADHD), Asthma, Asthma - Maintenance, Diabetes, Type 1, Oppositional Defiant Disorder, Seizure Prevention, Asthma - Acute, Anaphylaxis, Diabetes Mellitus, Seizure Prophylaxis, Allergic Asthma, Executive Function Disorder

Pain, Epilepsy Drug Lyrica May Increase Birth Defects Risk, Study Suggests

Posted 18 May 2016 by Drugs.com

WEDNESDAY, May 18, 2016 – The widely prescribed drug pregabalin (Lyrica) may slightly increase the risk for birth defects, a new study suggests. In a small study, researchers found that among women taking Lyrica during the first trimester of pregnancy, 6 percent had infants with major birth defects. In women who weren't taking the drug, 2 percent had a baby with a major birth defect, the study found. "These results should be taken with caution," said study senior author Dr. Thierry Buclin, from the Swiss Teratogen Information Service and the division of clinical pharmacology at the Lausanne University Hospital, in Switzerland. "It's a warning, but it cannot be taken as a certainty." Lyrica is prescribed for a range of health problems, including epilepsy, fibromyalgia and anxiety. The new study findings should be investigated further, Buclin said. "We should not unduly alarm ... Read more

Related support groups: Birth Control, Anxiety, Generalized Anxiety Disorder, Contraception, Anxiety and Stress, Fibromyalgia, Seizures, Lyrica, Social Anxiety Disorder, Epilepsy, Pregabalin, Delivery, Performance Anxiety, Hydrocephalus, Premature Labor, Labor Pain, Cesarean Section, Apnea of Prematurity, Brain Anomalies incl Congenital, Labor and Delivery including Augmentation

What a Change in DEA's Pot Rules Might Mean for Medical Research

Posted 11 May 2016 by Drugs.com

TUESDAY, May 10, 2016 – Most doctors approach medical marijuana with a great deal of uncertainty, because drug laws have hindered researchers' ability to figure out what pot can and can't do for sick patients. That could soon change. The U.S. Drug Enforcement Administration (DEA) is weighing whether to loosen its classification of marijuana, which would remove many restrictions on its use in medical research. If that occurs, doctors could start getting answers to the questions they regularly receive from patients regarding marijuana's clinical benefits. "I am asked as a practicing doctor even in a rural area about medical marijuana use, and I want to make sure I can give patients advice that's evidence-based," said Dr. Robert Wergin, board chair of the American Academy of Family Physicians. "We need those kinds of studies to help us give informed advice to our patients who ask about it ... Read more

Related support groups: Pain, Anxiety, Oxycodone, Anxiety and Stress, Percocet, OxyContin, Seizures, Morphine, Roxicodone, MS Contin, Methamphetamine, Endocet, Seizure Prevention, Kadian, Psychiatric Disorders, Percocet 10/325, Desoxyn, Roxicet, Avinza, Acetaminophen/Oxycodone

Eisai Announces FDA Approval of Fycompa (perampanel) Oral Suspension

Posted 2 May 2016 by Drugs.com

WOODCLIFF LAKE, N.J., May 2, 2016 /PRNewswire/ – Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Fycompa (perampanel) CIII Oral Suspension as adjunctive therapy for the treatment of partial-onset seizures (POS) with or without secondarily generalized seizures, and primary generalized tonic-clonic (PGTC) seizures in patients with epilepsy 12 years of age and older. The oral suspension formulation is a bioequivalent, interchangeable alternative to the Fycompa tablet formulation, and is expected to be available to patients in June 2016. "We are excited about the approval of Fycompa Oral Suspension, as it gives another option to patients with epilepsy who may have difficulty swallowing tablets or prefer liquids," said Lynn Kramer, M.D., Chief Clinical Officer and Chief Medical Officer, Neurology Business Group, Eisai. "The development of this new ... Read more

Related support groups: Seizures, Epilepsy, Fycompa, Perampanel

One-a-Day Anti-Seizure Drug Shows Promise for People With Epilepsy

Posted 15 Apr 2016 by Drugs.com

THURSDAY, April 14, 2016 – A once-daily epilepsy drug may control seizures just as well as a twice-daily drug, researchers report. Their preliminary study compared the once-a-day drug eslicarbazepine acetate (Aptiom) to the twice-daily drug carbamazepine (Tegretol, Carbatrol) for more than 800 people newly diagnosed with partial seizures, which originate in one area of the brain. After six months, 71 percent of those taking eslicarbazepine and 76 percent of those taking carbamazepine were seizure-free. After one year, 65 percent of those taking eslicarbazepine and 70 percent of those taking carbamazepine were seizure-free, said the team led by Dr. Elinor Ben-Menachem, of Gothenburg University in Sweden. The study was funded by Portuguese drug maker BIAL-Portela & Ca., and will be presented April 19 at the American Academy of Neurology's annual meeting, in Vancouver. "Seizure control is ... Read more

Related support groups: Seizures, Epilepsy, Tegretol, Carbamazepine, Seizure Prevention, Tegretol XR, Epitol, Seizure Prophylaxis, Carbatrol, Equetro, Aptiom, Eslicarbazepine

Study Sees No Link Between Common Epilepsy Drug, Certain Birth Defects

Posted 6 Apr 2016 by Drugs.com

WEDNESDAY, April 6, 2016 – Despite initial concern from early studies, taking the epilepsy drug lamotrigine (Lamictal) during pregnancy may not raise the risk for certain birth defects, a large new study finds. "An initial study of this drug showed an increased risk for cleft lip or cleft palate, but a number of other studies since have not, and our previous study showed an increased risk of clubfoot," said study author Helen Dolk, of Ulster University, in Northern Ireland. However, the new study, which had "a much larger population size – more than double the size of our previous study" – has found no significant links, Dolk said in a news release from the journal Neurology. The research, funded by the drug's maker, Glaxo Smith Kline, was published April 6 in the journal. In addition to being prescribed to control epileptic seizures, lamotrigine is used to prevent mood swings in ... Read more

Related support groups: Birth Control, Contraception, Seizures, Lamictal, Epilepsy, Lamotrigine, Seizure Prevention, Delivery, Lamictal XR, Seizure Prophylaxis, Vitamin/Mineral Supplementation during Pregnancy/Lactation, Premature Labor, Labor Pain, Lamictal Blue, Lamictal Orange, Brain Anomalies incl Congenital, Cesarean Section, Lamictal ODT, Lamictal CD, Lamictal Green

Type 1 Diabetes Linked to Epilepsy Risk, Study Suggests

Posted 1 Apr 2016 by Drugs.com

THURSDAY, March 31, 2016 – People who have type 1 diabetes may be nearly three times more likely to develop the seizure disorder epilepsy than people without type 1 diabetes, a new study suggests. The youngest people with type 1 diabetes – under 6 years old – seemed to be six times more likely to develop epilepsy, the researchers reported. But, those with the highest risk of epilepsy appeared to be children with type 1 diabetes who had to be treated in a hospital for a severe low blood sugar (hypoglycemia). The study found the risk of epilepsy was 16.5 times higher for these children. It should be noted, however, that the study did not establish a cause-and-effect relationship between the two conditions. And the "absolute" risk of any one person with type 1 diabetes going on to develop epilepsy remains very small. Epilepsy is a brain disorder affecting less than 1 percent of the U.S. ... Read more

Related support groups: Seizures, Insulin, Epilepsy, Diabetes, Type 1, Seizure Prevention, Seizure Prophylaxis

Even Controlled, Epilepsy May Still Cause Problems for Kids

Posted 31 Mar 2016 by Drugs.com

THURSDAY, March 31, 2016 – Even when their seizures are well-controlled, children with epilepsy can still have learning and behavioral disorders that lead to social and educational problems when they're young adults, a new study finds. "Frequency and intensity of seizures remain important predictors of how well a child does into adulthood. But, somewhat to our surprise we also found seizures are by no means the sole influencers of social and educational outcomes among adults with childhood epilepsy," said study lead author Anne Berg. Berg is a scientist with the Ann and Robert H. Lurie Children's Hospital of Chicago, and professor of pediatrics and neurology at Northwestern University Feinberg School of Medicine. The research included 241 children and teens in Connecticut who were diagnosed with uncomplicated epilepsy from 1993 to 1997. They were followed for an average of 12 years. ... Read more

Related support groups: Seizures, Epilepsy, Seizure Prevention, Seizure Prophylaxis, West Syndrome, Lennox-Gastaut Syndrome, Status Epilepticus

MS Patients May Be Prone to Other Chronic Illnesses, Study Finds

Posted 9 Mar 2016 by Drugs.com

WEDNESDAY, March 9, 2016 – People with multiple sclerosis (MS) are more likely to have other chronic health problems than those without the nervous system disorder, a new study indicates. Researchers looked at how common several chronic conditions – high blood pressure, diabetes, high cholesterol, heart disease, chronic lung disease, epilepsy, fibromyalgia, inflammatory bowel disease, depression, anxiety, bipolar disorder and schizophrenia – were in nearly 23,400 people newly diagnosed with MS and more than 116,600 people without MS. The MS patients had higher rates of all the conditions, with high cholesterol being the exception. Their rates of mental illness, particularly depression, were also high. Nineteen percent of MS patients and 9 percent of those without MS had depression, the study found. For many of the chronic conditions, there were significant gender differences. High ... Read more

Related support groups: High Blood Pressure, Diabetes, Type 2, Seizures, Hypertension, Asthma, Heart Disease, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis, Epilepsy, Heart Attack, High Cholesterol, Schizophrenia, Mania, Schizoaffective Disorder, Angina, Diabetic Neuropathy, Seizure Prevention, Upper Respiratory Tract Infection, Insulin Resistance, Diabetic Nerve Damage

Briviact Approved for Epileptic Seizures

Posted 24 Feb 2016 by Drugs.com

FRIDAY, Feb. 19, 2016 – Briviact (brivaracetam) has been approved by the U.S. Food and Drug Administration to treat partial onset seizures in people aged 16 and older with epilepsy. Partial onset seizures describe those that originate in a limited area of the brain, the FDA said Friday in a news release. Epilepsy, a common disorder believed to affect more than 5 million people in the United States, is characterized by recurring seizures, with typical symptoms including uncontrolled movement, muscle spasms and abnormal behavior. Common causes of epilepsy include stroke, infection, tumors, brain injury and abnormal brain development, the FDA said. In many cases, no cause can be identified, the agency added. Briviact, taken with other medications, was evaluated in clinical studies involving more than 1,500 people. Common side effects included drowsiness, dizziness and nausea. As with ... Read more

Related support groups: Seizures, Epilepsy, Briviact, Brivaracetam

FDA Approves Briviact (brivaracetam) to Treat Partial Onset Seizures

Posted 24 Feb 2016 by Drugs.com

February 19, 2016 – The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy. Epilepsy is a brain disorder that causes people to have recurring seizures. A seizure is an episode, usually of relatively short duration, of abnormal brain activity. Seizures can cause a variety of symptoms, including uncontrolled movements or spasms, abnormal thinking and behavior, and abnormal sensations. Muscle spasms can be violent, and loss of consciousness can occur. Seizures occur when clusters of nerve cells (neurons) in the brain undergo uncontrolled activation. A partial onset seizure begins in a limited area of the brain. “Patients can have different responses to the various seizure medicines that are available,” said Billy Dunn, M.D., director of t ... Read more

Related support groups: Seizures, Epilepsy, Seizure, Seizure Prevention, Seizure Prophylaxis, Briviact, Brivaracetam

FDA Medwatch Alert: Magnesium Sulfate in Water for Injection by Hospira: Recall - Incorrect Barcode Labeling on the Primary Container

Posted 7 Jan 2016 by Drugs.com

ISSUE: Hospira, Inc. announced a voluntary recall of one lot of MAGNESIUM SULFATE IN WATER FOR INJECTION (0.325 mEq Mg**/mL) 40 mg/mL 2g total, 50 mL (NDC: 0409-6729-24, Lot 53-113-JT, Expiry 1NOV2016) to the user level due to a confirmed customer report of an incorrect barcode on the primary bag labeling. The product has a barcode identifying the product contents on both the overwrap and on the primary container. The barcode on the overwrap is correct; however, there is potential for the primary container barcode to be mislabeled with the barcode for HEPARIN SODIUM 2000 USP UNITS/1000 mL in 0.9% SODIUM CHLORIDE INJECTION. The product is labeled with the correct printed name on the primary container and overwrap. See the Press Release for product photos. If the incorrect barcode on Magnesium Sulfate in Water for Injection is not detected prior to dispensing or administration to a ... Read more

Related support groups: Seizures, Epsom Salt, Magnesium Sulfate, Sulfamag

Page 1 2 3 4 5 Next

Ask a Question

Further Information

Related Condition Support Groups

Seizure Prevention, Seizure Prophylaxis, Epilepsy

Related Drug Support Groups

Valium, Topamax, diazepam, Keppra, topiramate, Dilantin, Trileptal, progesterone, phenobarbital, view more... levetiracetam, oxcarbazepine, phenytoin, Vimpat, zonisamide, primidone, Zonegran, valproic acid, Keppra XR, pyridoxine, Zarontin, Vitamin B6, Mysoline, lacosamide, Depakene, Fycompa, Aptiom, Potiga, Phenytoin Sodium, ethosuximide, Diastat, Stavzor, Topamax Sprinkle, Gabitril, Pentothal, Oxtellar XR, Trokendi XR, vigabatrin, Briviact, Phenytek, perampanel, Valrelease, Spritam, Qudexy XR, thiopental, Luminal, Sabril, Diastat AcuDial, Roweepra, Depacon, Aminoxin, Elepsia XR, Vitelle Nestrex, Topiragen, Solfoton, Celontin, trimethadione, ezogabine, Peganone, Diazepam Intensol, eslicarbazepine, tiagabine, Dizac, methsuximide, Tridione, Nestrex, brivaracetam, Zetran, Diastat Pediatric, ethotoin